In a study in breast cancer cells, the combination of lapatinib, a dual HER2/neu and EGFR tyrosine kinase inhibitor, with INK128 prevented each HER2 and HER3 phosphorylation induced by INK128 and made synergistic induction of cell Loss of life in numerous HER2-constructive cell lines resistant to trastuzumab and lapatinib. In https://louissychj.blogofoto.com/59721191/the-basic-principles-of-7-methylxanthine